Capital Berg

Keeps People Up-To-Date

Thursday, February 25, 2021
Log in
  • United States
  • Business
  • Health
  • Science
  • Technology
  • About CapitalBerg
    • Analysts & Contributors
    • Advertising
    • Contact US
    • Privacy Policy GDPR
    • Terms of Use

Pages

  • About CapitalBerg
  • Advertising
  • Analysts & Contributors
  • Contact US
  • Investor Relations
  • Privacy Policy GDPR
  • SEC Disclosure
  • Terms of Use

Recent Posts

  • Tennessee Rapist Breaks into Woman’s House Three Times the Same Night to Assault Her June 29, 2018
  • Mentally Ill Man Arrested After Breaking into Retirement Home to Grope a Woman’s Chest June 28, 2018
  • “Syndrome” Author Blake Leibel Sentenced to Life in Prison for the Murder and Torture of Girlfriend June 27, 2018
  • Michigan Dad to Be Sentenced in the Beating Death of 3-Year-Old Infant June 26, 2018
  • Ohio Patrolman Booted from Police After Pulling Over His Daughter and Boyfriend June 26, 2018
  • Utah Mayor Shares Heartwarming Letter of Man Apologizing for Stealing a Stop Sign 75 Years Ago June 25, 2018
  • Mississippi Man Beheaded Mother After A Spat over Credit Cards June 25, 2018

BioMarin Recalls Kyndrisa from EU Markets

June 1, 2016 By Andreas Petersen

BioMarin Headquarters in San Rafael, California

The California-based pharmaceutical company will have to resist new treatment rejection on both US and EU markets.

BioMarin, the pharmaceutical company, recently announced that it will stop the development of a muscular dystrophy treatment that was undergoing in the European market. The recall came after the European Medicines Agency offered a negative opinion on the effectiveness of the cure.

BioMarin Market Tentatives

The company, which already tried and failed to enter the US market with the new treatment, has also received a negative review from the European legislators. It is thus forced to discontinue the treatments and to retract the existing medicines from the market.

BioMarin will also have to stop the projects of three other products that are currently in Phase II of the development.

The pharmaceutical company decided to join efforts with regulatory authorities, doctors, and patient groups in order to offer a transition plan for patients that are currently following the soon-to-be stopped Kyndrisa treatment.

The decision had an adverse impact on the company’s stocks, which dropped 29% in comparison with the same period of the last year.

The company is intending to continue the development of oligonucleotides that are used in the cure of Duchene Muscular Dystrophy, as it is in a continuous fight to protect its patent. Last fall, BioMarin just fought and won Sarepta on an initial ruling concerning this matter.

This new treatment was a project based on the 2014 BioMarin acquisition of Prosensa. Soon after the tests showed that the pills had little to no effects, GlaxoSmithKline refused to continue the collaboration with BioMarin. Still, the company continued the cure development by itself and tried to find a treatment solution that would delay the disease progression.

Treatments for Muscular Dystrophy

MDM is a genetic disorder involving muscle degeneration and weakness in boys. The prevalence is one in 3,500 – 5,000 cases. DMD is an effect of dystrophin absence. The symptoms appear in early childhood, and by adolescence, it gets to affect the heart and the respiratory muscles.

Despite the fact that the medicines were withdrawn from the EU market, BioMarin expects to have excellent results in prospecting different solutions for MDM in 2017.

Another pharmaceutical company that intends to obtain approval for an MDM treatment is Sarepta Therapeutics. Last week, the company announced that the Food and Drug Administration has prolonged the term of issuing an opinion on its new medicine, eteplirsen. Sarepta Therapeutics still has hopes that the approval will come soon.

Image Source: Wikipedia

  • About the Author

About Andreas Petersen

Andreas was too little to remember when he and his parents first set foot in America. He considers himself a true American citizen, but uses every opportunity to promote his Danish origins. He is deeply found of politics, all nations’ politics and generally looks forward to the presidential elections. His BA degree in Political Sciences has helped him get familiar to the constitutional frames of US and non-US nations.

Filed Under: Health Tagged With: BioMarin, BioMarin Recalls Kyndrisa from EU Markets, FDA, Food and Drug Administration, Kyndrisa, MDM treatment, Muscular Dystrophy, Sarepta Therapeutics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 44 other subscribers

Recent Articles

sleep

Tennessee Rapist Breaks into Woman’s House Three Times the Same Night to Assault Her

June 29, 2018 By Denise Ehrlich Leave a Comment

police lights

Mentally Ill Man Arrested After Breaking into Retirement Home to Grope a Woman’s Chest

June 28, 2018 By Waleed Javed Leave a Comment

gavel

“Syndrome” Author Blake Leibel Sentenced to Life in Prison for the Murder and Torture of Girlfriend

June 27, 2018 By Andreas Petersen Leave a Comment

Woods

Michigan Dad to Be Sentenced in the Beating Death of 3-Year-Old Infant

June 26, 2018 By Marlene R. Litten Leave a Comment

patrol cruiser

Ohio Patrolman Booted from Police After Pulling Over His Daughter and Boyfriend

June 26, 2018 By Waleed Javed Leave a Comment

stop sign

Utah Mayor Shares Heartwarming Letter of Man Apologizing for Stealing a Stop Sign 75 Years Ago

June 25, 2018 By June Harris Leave a Comment

Butter knives

Mississippi Man Beheaded Mother After A Spat over Credit Cards

June 25, 2018 By Carol Harper Leave a Comment

XXXTentacion mugshot

Florida Authorities Arrested Suspect in Connection with Shooting of XXXTentacion

June 22, 2018 By Waleed Javed Leave a Comment

sunset over beach

Dallas Mother Accused of Beating Four-Year-Old and Dumping Body Into the Water

June 21, 2018 By Denise Ehrlich Leave a Comment

chicken Alfredo

Ohio Man Sentenced for Trying to Seduce Teenage Boy with Naked Pictures and Chicken Alfredo

June 20, 2018 By Marlene R. Litten Leave a Comment

bedroom

South Carolina Teen and Mates End Up In Slammer for Raping a Teenage Girl

June 19, 2018 By Waleed Javed Leave a Comment

cyberstalkin

California Man Arrested for Stalking Ex-Girlfriend, Hacking Her Online Accounts

June 19, 2018 By June Harris Leave a Comment

hammer

Naked Patient Sneaks out of Emergency Room to Bash Homeowner’s Head with Hammer

June 18, 2018 By Carol Harper Leave a Comment

screwdriver

Middle School Student Attacks Teacher During Class with Screwdriver

June 18, 2018 By Andreas Petersen Leave a Comment

Related Articles

  • Virtual reality

    French Hospital Employs Virtual Reality to Curb Patient’s Pain

    Jun 13, 2018
  • surgery

    Danish Doctors Baffled by Patient Remaining Awake after During Cardiac Arrest

    Jun 5, 2018
  • medical implant

    MIT Think-Thanks Designed the World’s First Wireless Medical Implant

    Jun 5, 2018
  • human eye

    Australian Woman Nearly Goes Blind Because She Forgot to Remove her Makeup

    Jun 4, 2018
  • Snorting Condoms Challenge.

    Snorting Condoms Challenge on the Rise, Health Officials Declared

    Apr 2, 2018
  • Florida Woman Mommy Belly

    Florida Woman Mistook Labor Pains for Food Poisoning

    Mar 30, 2018
  • Surgical sponges.

    Japanese Surgeons Discovered Surgical Sponges in Women’s Abdomen

    Feb 23, 2018
  • British accent cards.

    Texas Woman Goes to Sleep, Wakes Up with British Accent

    Feb 13, 2018
  • Woodpeckers and CTE

    Woodpeckers Not Invulnerable to Brain Damage, New Study Suggests

    Feb 6, 2018
  • Gummy beart

    New Mexico School Students Intoxicated After Eating Marijuana-Laced Gummy Bears

    Jan 24, 2018

Categories

  • Business
  • Deals
  • Health
  • Science
  • Technology
  • United States
  • World

Copyright © 2021 capitalberg.com

About · Privacy Policy · Terms of Use · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.